Related Experiment Video
Updated: Jun 26, 2026
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
Published on: July 28, 2020
[Multidisciplinary treatment for adult soft tissue sarcoma]
1Nationales Centrum für Tumorerkrankungen Medizinische Onkologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 350, Heidelberg, Germany. florian.lordick@med.uni-heidelberg.de
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|January 22, 2009
Summary
Organ-preserving surgery for soft tissue sarcomas is now standard, aided by adjuvant radiation therapy for local tumor control. However, survival rates and prognosis remain unchanged, highlighting the need for targeted therapies.
Area of Science:
- Oncology
- Surgical Oncology
- Radiation Oncology
Context:
- Shift from mutilating resections to organ- and function-preserving surgery for soft tissue sarcomas.
- Multidisciplinary treatment approaches, including adjuvant radiation therapy, have enabled this shift.
- Adjuvant radiation improves local tumor control in high-risk sarcomas but not overall survival.
Purpose:
- To review the current standards in soft tissue sarcoma treatment.
- To evaluate the impact of adjuvant radiation and perioperative chemotherapy on prognosis.
- To identify future directions for improving patient outcomes.
Summary:
- Organ- and function-preserving surgery represents the current standard for soft tissue sarcomas.
- Adjuvant radiation therapy significantly enhances local tumor control after resection, particularly in high-risk cases.
- Despite advances in surgical techniques and adjuvant therapies, overall survival and prognosis for soft tissue sarcomas have not improved globally.
Impact:
- Current treatment strategies, including adjuvant radiation and perioperative chemotherapy, have not improved overall survival for soft tissue sarcomas.
- Understanding sarcoma pathogenesis and molecular profiles is crucial for developing effective targeted therapies, exemplified by imatinib for gastrointestinal stromal tumors.
- Early referral to expert multidisciplinary centers is the most effective measure to improve prognosis for soft tissue sarcoma patients.
More Related Videos
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...